Tonix Pharmaceuticals Holding (TNXP) Cash from Investing Activities (2011 - 2026)

Tonix Pharmaceuticals Holding has reported Cash from Investing Activities for 16 years, with the latest figure at -$587000.0 in Q2 2026.

• On a quarterly basis, Cash from Investing Activities rose 76.88% year-over-year to -$587000.0 in Q2 2026; TTM through Jun 2026 was -$4.3 million, a 66.68% decrease from a year earlier, with the FY2025 full-year figure at -$4.5 million, down 3673.33% from the prior year.
• Cash from Investing Activities was -$587000.0 for Q2 2026 at Tonix Pharmaceuticals Holding, up from -$1.7 million in the prior quarter.
• The five-year high for Cash from Investing Activities was -$3000.0 in Q4 2024, with the low at -$24.0 million in Q2 2023.
• Average Cash from Investing Activities over 5 years is -$4.9 million, with a median of -$1.0 million recorded in 2025.
• The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities soared 99.3% in 2024, then plunged 33933.33% in 2025.
• Over 5 years, Cash from Investing Activities stood at -$4.7 million in 2022, then surged by 90.77% to -$431000.0 in 2023, then jumped by 99.3% to -$3000.0 in 2024, then slumped by 33933.33% to -$1.0 million in 2025, then soared by 42.51% to -$587000.0 in 2026.
• The last three Cash from Investing Activities figures came in at -$587000.0 (Q2 2026), -$1.7 million (Q1 2026), and -$1.0 million (Q4 2025), per Business Quant data.